No Cover Image

Conference Paper/Proceeding/Abstract 503 views

Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines

M Moe, M Almatari, P Ali, P Willshaw, Peter Willshaw

Journal of Clinical Oncology, Volume: 27, Issue: 15, Start page: supplement S

Swansea University Author: Peter Willshaw

Full text not available from this repository: check for access using links below.

Check full text

Published in: Journal of Clinical Oncology
ISSN: 0732-183X
Published: 2009
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa10808
first_indexed 2013-07-23T12:04:19Z
last_indexed 2024-11-14T11:08:41Z
id cronfa10808
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2023-06-26T16:42:59.2529641</datestamp><bib-version>v2</bib-version><id>10808</id><entry>2012-05-29</entry><title>Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines</title><swanseaauthors><author><sid>4cb70423fbd01750747f24fd7cc2e410</sid><firstname>Peter</firstname><surname>Willshaw</surname><name>Peter Willshaw</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2012-05-29</date><abstract/><type>Conference Paper/Proceeding/Abstract</type><journal>Journal of Clinical Oncology</journal><volume>27</volume><journalNumber>15</journalNumber><paginationStart>supplement S</paginationStart><paginationEnd/><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0732-183X</issnPrint><issnElectronic/><keywords/><publishedDay>20</publishedDay><publishedMonth>5</publishedMonth><publishedYear>2009</publishedYear><publishedDate>2009-05-20</publishedDate><doi/><url/><notes/><college>COLLEGE NANME</college><CollegeCode>COLLEGE CODE</CollegeCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-06-26T16:42:59.2529641</lastEdited><Created>2012-05-29T15:04:51.1205247</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>M</firstname><surname>Moe</surname><order>1</order></author><author><firstname>M</firstname><surname>Almatari</surname><order>2</order></author><author><firstname>P</firstname><surname>Ali</surname><order>3</order></author><author><firstname>P</firstname><surname>Willshaw</surname><order>4</order></author><author><firstname>Peter</firstname><surname>Willshaw</surname><order>5</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2023-06-26T16:42:59.2529641 v2 10808 2012-05-29 Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines 4cb70423fbd01750747f24fd7cc2e410 Peter Willshaw Peter Willshaw true false 2012-05-29 Conference Paper/Proceeding/Abstract Journal of Clinical Oncology 27 15 supplement S 0732-183X 20 5 2009 2009-05-20 COLLEGE NANME COLLEGE CODE Swansea University 2023-06-26T16:42:59.2529641 2012-05-29T15:04:51.1205247 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine M Moe 1 M Almatari 2 P Ali 3 P Willshaw 4 Peter Willshaw 5
title Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
spellingShingle Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
Peter Willshaw
title_short Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
title_full Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
title_fullStr Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
title_full_unstemmed Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
title_sort Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
author_id_str_mv 4cb70423fbd01750747f24fd7cc2e410
author_id_fullname_str_mv 4cb70423fbd01750747f24fd7cc2e410_***_Peter Willshaw
author Peter Willshaw
author2 M Moe
M Almatari
P Ali
P Willshaw
Peter Willshaw
format Conference Paper/Proceeding/Abstract
container_title Journal of Clinical Oncology
container_volume 27
container_issue 15
container_start_page supplement S
publishDate 2009
institution Swansea University
issn 0732-183X
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 0
active_str 0
published_date 2009-05-20T03:18:29Z
_version_ 1851542690644099072
score 11.090091

Similar Items